Amanita muscaria coconut oil is a topical preparation, and topical is not a quiet version of oral — it is a different pharmacology. Muscimol and ibotenic acid are strongly water-loving molecules (XLogP −1.4 and −3.9), which makes them poor candidates twice over: poor to extract into oil, and poor at crossing intact skin. The coconut oil base has human trial evidence behind it. The mushroom fraction has none.
Our Amanita muscaria in cosmetology article covers what the mushroom contributes to skincare formulations in general. This page is narrower and more awkward: it takes one specific jar off the shelf, asks whether the active compounds can physically get where the label implies, and separates the part of the product that has evidence from the part that doesn't.
What's Actually in the Jar?
Two things: unrefined coconut oil and dried Amanita muscaria, cold-infused together over roughly two weeks, sold as 200 ml for €49. There is no solvent, no heat step, and no standardisation — which matters more than it sounds, and we'll get to why.
| Component | What it contributes | Human evidence for that contribution |
|---|---|---|
| Unrefined coconut oil | Emollient, barrier support, antibacterial (lauric acid) | Two randomised trials, both positive |
| Dried Amanita muscaria | Muscimol, ibotenic acid, muscarine traces, pigments | None for topical use, in any species |
That table is the whole article in miniature. The ingredient people buy the product for is the one with no topical evidence, and the ingredient people treat as filler is the one with randomised trials.
Why "It's a Small Molecule" Is the Wrong Argument
The usual defence of topical fly agaric runs like this: muscimol weighs 114 daltons, the skin admits molecules under 500 daltons, so muscimol gets in. The first two facts are correct. The conclusion doesn't follow.
The 500-dalton figure comes from Bos and Meinardi's 2000 review, which observed that essentially every contact allergen, every topical drug, and every transdermal patch ingredient sits under 500 daltons (PMID 10839713). Read it carefully and it's a ceiling, not a passport. Being under the limit is necessary. It was never sufficient.
The reason is that the outer skin layer, the stratum corneum, is a lipid barrier — keratin-filled cells mortared together with ceramides, cholesterol and fatty acids. To cross it passively, a molecule has to be willing to dissolve in fat. Willingness to dissolve in fat is what logP measures. Here is what happens when you put the numbers side by side:
| Molecule | Molecular weight | XLogP | Crosses intact skin passively? |
|---|---|---|---|
| Muscimol | 114.10 Da | −1.4 | Poorly — prefers water ~25:1 |
| Ibotenic acid | 158.11 Da | −3.9 | Very poorly — prefers water ~8,000:1 |
| Scopolamine | 303.35 Da | 0.9 | Yes — licensed transdermal patch exists |
Look at what that comparison does to the size argument. Scopolamine is nearly three times heavier than muscimol, and scopolamine is the one with a prescription skin patch on the market. Muscimol is the featherweight, and muscimol is the one that struggles. Size was never the gate. Fat-solubility is, and both fly agaric alkaloids fail that test badly — ibotenic acid worst of all, because it exists as a zwitterion, carrying a positive and a negative charge at once. Charged molecules and lipid membranes get along about as well as you'd expect.
The Extraction Problem That Comes First
Before skin permeation is even a question, there's an earlier bottleneck: how much muscimol ends up in the oil at all. A cold infusion works on the oldest rule in chemistry — like dissolves like. Coconut oil is a triglyceride, about as non-polar a solvent as a kitchen produces. Muscimol's XLogP of −1.4 means that given a choice between oil and water, roughly 25 parts go to the water for every one that goes to the oil. For ibotenic acid the ratio is closer to 8,000 to 1.
So the same property sinks the product twice. The compounds don't want to leave the mushroom for the oil, and what little does make the trip doesn't want to leave the oil for your skin. Both bottlenecks trace back to one number.
Is there an assay showing how much muscimol a two-week cold coconut oil infusion actually captures? Not that we can find, and we've looked. No manufacturer publishes one, ours included. Anyone quoting you a milligram figure for an oil infusion is estimating from the dry mushroom input and hoping extraction was complete. Physical chemistry says it wasn't.
So What Is the Coconut Oil Doing?
Working, mostly. In a randomised double-blind trial of 117 children with mild to moderate atopic dermatitis, virgin coconut oil cut SCORAD severity scores by 68.23% against 38.13% for mineral oil, and the gap was significant at P < 0.001 (PMID 24320105). That is a large effect for an emollient, and mineral oil is a genuinely active comparator rather than a sugar pill.
The second trial is stranger and more interesting. Verallo-Rowell and colleagues randomised 52 adults with atopic dermatitis to virgin coconut oil or virgin olive oil twice daily for four weeks and cultured their skin for Staphylococcus aureus. Among coconut oil users who started colonised, 1 in 20 was still colonised at four weeks. Among olive oil users, 6 of 12 were (PMID 19134433). Lauric acid, which makes up roughly half the fat in coconut oil, has real antibacterial activity, and that trial is the cleanest human demonstration of it.
Two honest caveats. Both trials tested plain virgin coconut oil, not a mushroom infusion, so they license claims about the base and nothing else. And both studied atopic dermatitis specifically, not joint pain, not massage, not "skin regeneration" in a general sense.
Has Topical Amanita Muscaria Ever Been Tested?
No. We ran the search rather than assuming: querying PubMed in August 2026 for Amanita muscaria combined with topical, dermal, skin, ointment or salve returns four records in total. Two are 2025 papers on lead and cadmium concentrations in fly agaric. One is a 2023 survey of why and how people ingest it. One is a 2011 clinical series on acute poisonings. Not one is a trial of putting it on skin.
Four records is not a thin evidence base. Four records is an absent one. Worth stating plainly, because a product page that lists muscimol and ibotenic acid under "key active compounds" implies a body of work that does not exist.
Where the Folk Record Actually Points
Fly agaric salves are genuinely traditional. Northern European and Siberian practice records fat- or oil-based preparations rubbed into aching joints and tired muscle, and our fly agaric in folk medicine article covers that lineage. Tradition earns a product a hearing. It doesn't substitute for a trial.
One piece of folklore should be actively dropped, though, because it gets recycled constantly in marketing copy: the witches' flying ointment. Those preparations were Solanaceae — belladonna, henbane, mandrake — simmered into animal fat. Their tropane alkaloids are lipophilic enough to cross skin from a fat base, which is exactly why the tradition worked well enough to terrify medieval Europe. Amanita was not the mushroom in that story, and its alkaloids have the opposite solubility profile. Borrowing the flying-ointment mystique for a fly agaric product borrows the wrong pharmacology.
Can You Microdose Through Skin?
No, and the reason isn't caution — it's that three unknowns multiply. The most common misuse of this product is treating it as a needle-free microdose. It isn't one, and it can't be made into one.
Oral microdosing protocols work — to whatever extent they work — because they start from a known quantity of dried mushroom. You can weigh 0.5 g. Our microdosing guide is built on that denominator. Topical application destroys it. You would need the extraction efficiency of the infusion, the permeation rate through your particular skin at that particular site, and the true surface area covered. None of the three is known, and they multiply. A "microdose per application" figure for an oil is a number someone made up.
A related wrinkle: this product is described elsewhere on our site as suitable for culinary use as well as topical. Eating it is a different decision with a different risk profile and a different dose logic, and nothing in this article should be read as guidance for that. If you want the oral route, use a form you can weigh — see our tincture guide and safety checklist instead.
Broken Skin Changes the Rules
Everything above assumes intact skin, because the stratum corneum is the barrier — a layer only 10 to 20 micrometres thick over most of the body, doing all of the gatekeeping. Remove it and the arithmetic inverts. Eczematous, cracked, abraded or freshly shaved skin loses the lipid gatekeeper that keeps hydrophilic molecules out, and water-loving compounds that cannot cross healthy skin cross damaged skin far more readily.
So the standard "don't apply to broken skin" warning isn't boilerplate here — it's the one situation where meaningful absorption becomes plausible, and it's also the situation where you have the least control over how much. Same goes for mucous membranes, which have no stratum corneum at all. Keep it away from eyes, mouth, and genital skin.
Two more: don't use it on children, and don't leave it where a dog can lick a treated limb. Fly agaric poisoning in pets is not rare, and our pet safety article exists because of it.
Who Should Skip It?
Five groups, and the first one is the firmest. Pregnant and breastfeeding women, because there is no safety data of any kind for topical fly agaric and the honest position is refusal rather than reassurance. Anyone with a coconut allergy — uncommon, but real, and the base is 99% of the jar. Children. Anyone with widespread broken or inflamed skin, per the section above. And anyone hoping for a psychoactive effect, who should skip it for a different reason: they're going to be disappointed, and chasing the effect by scaling up the amount or the area is precisely the wrong instinct.
How to Use It Sensibly
Patch test first — a coin-sized amount on the inner forearm, left 24 to 48 hours. Infused oils carry plant and fungal proteins that plain oil doesn't, and contact reactions are the realistic adverse event here, not neurotoxicity.
After that, treat it as what the evidence supports: a good emollient with an unproven addition. Massage it into dry skin or aching muscle, use a small amount, and give it three to four weeks before judging. Coconut oil melts around 24 °C, so it will be solid in a cool room and liquid in a warm one — that's normal, not spoilage. Store it away from light and heat, which is the same advice as our storage guide gives for the dried mushroom, and for the same oxidation reasons.
What should you track? Dryness, itch, and how the skin feels 12 hours after application rather than 2 minutes after. If you're using it on a joint, track the joint at a fixed time of day. And be honest with yourself about the comparison you're actually running: against nothing, or against the plain coconut oil you could buy for a tenth of the price?
Frequently Asked Questions
Can Amanita muscaria coconut oil cause psychoactive effects?
Through intact skin, no — and not because the dose is small but because the chemistry is wrong. Muscimol's XLogP of −1.4 means it partitions away from lipid, so it neither extracts well into oil nor crosses the stratum corneum well. There is no published human study of topical fly agaric reporting any central effect.
How much muscimol is in the oil?
Nobody knows, including us. No published assay measures muscimol recovery from a cold coconut oil infusion, and the compound's solubility profile predicts poor extraction. Any specific milligram claim you see for an infused oil is back-calculated from the dry mushroom input, which assumes complete extraction that almost certainly didn't happen.
Can you eat it?
Our product description mentions culinary use, but this guide covers topical application only. Oral use is a separate decision requiring a weighable dose, and an infused oil gives you no reliable way to know what you're taking. For oral routes, a tincture or weighed dried material gives you a denominator that an oil does not.
Is it safe on eczema or broken skin?
Plain virgin coconut oil is well studied in eczema and performed strongly in a 117-child randomised trial (PMID 24320105). The infused version is different: broken skin bypasses the barrier that keeps muscimol and ibotenic acid out, so absorption becomes unpredictable exactly where you can least control it. Use plain coconut oil on compromised skin.
How long before I can tell if it's working?
Give it three to four weeks of consistent use, tracking one or two specific measures rather than a general impression. Emollient effects on dryness usually show within days to a week. If you see nothing at four weeks, the sensible conclusion is that the infusion isn't adding anything the base oil wasn't already doing.
Shop Amanita Muscaria Coconut Oil
Buy Amanita muscaria coconut oil (200 ml, €49) if you want the traditional preparation and accept what's known and unknown about it. The Amanita muscaria collection also holds fly agaric soap and tincture, the latter being the form to choose if a measurable dose is what you're after. Free shipping on orders over €50.
Related Articles
- Amanita Muscaria in Cosmetology: Natural Skin Care
- Ibotenic Acid vs Muscimol: What's the Difference?
- How Fly Agaric Active Compounds Affect the Human Body
- Fly Agaric in Folk Medicine
- Amanita Muscaria Safety Checklist
- How to Use Amanita Tincture
Sources
- Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-169. PubMed 10839713
- Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol. 2014;53(1):100-108. PubMed 24320105
- Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermatitis. 2008;19(6):308-315. PubMed 19134433
- National Center for Biotechnology Information. PubChem Compound Summary for CID 4266, Muscimol. PubChem CID 4266
- National Center for Biotechnology Information. PubChem Compound Summary for CID 1233, Ibotenic acid. PubChem CID 1233